13F filing recap · Q2 2011

What did Icahn Capital LP buy in Q2 2011?

Reported stock-position changes between this filing and the previous one.

Stock value

$11.18B

Positions

Estimated turnover

59.8%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

FRXForest Laboratories Inc$782.70Mreported value+19.90M shares VGRVector Group Ltd$250.75Mreported value+14.10M shares AMLNAmylin Pharmaceuticals, Inc.$192.14Mreported value+14.38M shares OSKOshkosh Corporation$72.33Mreported value+2.50M shares CMCCommercial Metals Company$69.66Mreported value+4.85M shares

Increased positions

IEPIcahn Enterprises L.p.$3.41Breported value+783.4K shares+1.0%MSIMotorola, Inc.$1.76Breported value+30.63M shares+400.0%CLXClorox Co /de/$843.00Mreported value+10.00M shares+400.0%MMIMotorola Mobility Holdings Inc$738.47Mreported value+26.80M shares

Exited positions

BIIBBiogen Inc.$235.95Mprior reported value-3.22M shares-100.0%GENZGenzyme Corp.$199.51Mprior reported value-2.62M shares-100.0%LWSNLawson Software Inc$43.19Mprior reported value-3.57M shares-100.0%CYBXCyberonics, Inc$15.35Mprior reported value-482.4K shares